Format

Send to

Choose Destination
Br J Clin Pharmacol. 1999 Jul;48(1):15-8.

Status of new medicines approved by the European Medicines Evaluation Agency regarding paediatric use.

Author information

1
Academic Division of Child Health, (University of Nottingham), Derbyshire Children's Hospital, Derby, UK.

Abstract

AIMS:

To evaluate the activity of the European Medicines Evaluation Agency with regard to the registration for paediatric use of new medicines granted a marketing authorization.

METHODS:

European Public Assessment Reports published on the Internet from January 95 until April 98 have been analysed using the browser Microsoft Explorer and the software Adobe Acrobat Reader.

RESULTS:

Of the 45 new substances licensed since January 95, 29 (64%) were of possible use in children but only 10 were licensed for paediatric use. For the 19 drugs of possible use in children, but not approved for such a use, in nine instances (47%) their summary of product characteristics reported that their use in children has not been established.

CONCLUSIONS:

A change of practice by pharmaceutical companies and regulatory authorities is imperative so that children are not precluded from having the same rights to medicines as adults.

PMID:
10383554
PMCID:
PMC2014872
DOI:
10.1046/j.1365-2125.1999.00981.x
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center